CYT - サイテック・インダストリ―ズ ()

CYTのニュース

   Cyteir Therapeutics Names Adam Veness General Counsel  2022/04/25 13:00:00 Kwhen Finance
   Cyteir Therapeutics Inc Shares Close the Week 25.8% Lower - Weekly Wrap  2022/01/18 08:49:56 Kwhen Finance
Cyteir Therapeutics Inc (CYT) shares closed this week 25.8% lower than it did at the end of last week. The stock is currently down 46.2% year-to-date, down 64.8% over the past 12 months, and down 64.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Shares traded as high as $8.78 and as low as $5.99 this week.Shares closed 73.5% below its 52-week high and 2.2% above its 52-week low.Trading volume this week was 11.3% lower than the 10-day average and 60.5% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1200.9% The company's stock price performance over the past 12 months lags the peer average by -451.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Cyteir Therapeutics Inc Shares Approach 52-Week Low - Market Mover  2022/01/13 11:19:25 Kwhen Finance
Cyteir Therapeutics Inc (CYT) shares closed today at 0.1% above its 52 week low of $7.20, giving the company a market cap of $255M. The stock is currently down 36.6% year-to-date, down 58.6% over the past 12 months, and down 58.6% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%. Trading Activity Trading volume this week was 216.1% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1661.9% The company's stock price performance over the past 12 months lags the peer average by -555.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Cyteir Therapeutics Inc Shares Close the Day 10.3% Lower - Daily Wrap  2022/01/13 11:19:25 Kwhen Finance
Cyteir Therapeutics Inc (CYT) shares closed today 10.3% lower than it did at the end of yesterday. The stock is currently down 36.6% year-to-date, down 58.6% over the past 12 months, and down 58.6% over the past five years. Today, the Dow Jones Industrial Average rose 0.1%, and the S&P 500 rose 0.3%. Trading Activity Shares traded as high as $9.09 and as low as $7.20 this week.Shares closed 68.8% below its 52-week high and 0.1% above its 52-week low.Trading volume this week was 236.7% higher than the 10-day average and 216.1% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1661.9% The company's stock price performance over the past 12 months lags the peer average by -555.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Cyteir Therapeutics Announces First Patient Dosed in Phase 1 Combination Trial With CYT-0851  2022/01/12 12:30:00 Kwhen Finance
   Cyteir Therapeutics Names Adam Veness General Counsel  2022/04/25 13:00:00 Kwhen Finance
   Cyteir Therapeutics Inc Shares Close the Week 25.8% Lower - Weekly Wrap  2022/01/18 08:49:56 Kwhen Finance
Cyteir Therapeutics Inc (CYT) shares closed this week 25.8% lower than it did at the end of last week. The stock is currently down 46.2% year-to-date, down 64.8% over the past 12 months, and down 64.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.9%, and the S&P 500 fell 0.3%. Trading Activity Shares traded as high as $8.78 and as low as $5.99 this week.Shares closed 73.5% below its 52-week high and 2.2% above its 52-week low.Trading volume this week was 11.3% lower than the 10-day average and 60.5% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index this week, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1200.9% The company's stock price performance over the past 12 months lags the peer average by -451.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Cyteir Therapeutics Inc Shares Approach 52-Week Low - Market Mover  2022/01/13 11:19:25 Kwhen Finance
Cyteir Therapeutics Inc (CYT) shares closed today at 0.1% above its 52 week low of $7.20, giving the company a market cap of $255M. The stock is currently down 36.6% year-to-date, down 58.6% over the past 12 months, and down 58.6% over the past five years. This week, the Dow Jones Industrial Average fell 1.4%, and the S&P 500 fell 1.6%. Trading Activity Trading volume this week was 216.1% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1661.9% The company's stock price performance over the past 12 months lags the peer average by -555.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Cyteir Therapeutics Inc Shares Close the Day 10.3% Lower - Daily Wrap  2022/01/13 11:19:25 Kwhen Finance
Cyteir Therapeutics Inc (CYT) shares closed today 10.3% lower than it did at the end of yesterday. The stock is currently down 36.6% year-to-date, down 58.6% over the past 12 months, and down 58.6% over the past five years. Today, the Dow Jones Industrial Average rose 0.1%, and the S&P 500 rose 0.3%. Trading Activity Shares traded as high as $9.09 and as low as $7.20 this week.Shares closed 68.8% below its 52-week high and 0.1% above its 52-week low.Trading volume this week was 236.7% higher than the 10-day average and 216.1% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -1661.9% The company's stock price performance over the past 12 months lags the peer average by -555.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Cyteir Therapeutics Announces First Patient Dosed in Phase 1 Combination Trial With CYT-0851  2022/01/12 12:30:00 Kwhen Finance

calendar